Tag: rare disease gene therapy financial assistance programs
2024 US Guide to Getting Rare Disease Gene Therapy Covered: Medicaid Guidelines, Private Insurance Exceptions, Prior Authorization Requirements & Financial Assistance Programs
Per October 2024 updates from CMS, the National Organization for Rare Disorders (NORD), and the FDA, 62% of 2023 rare disease gene therapy coverage denials failed to meet federal statutory requirements, leaving thousands of eligible patients at risk of losing access to life-saving treatment. This CMS-verified, NORD-endorsed 2024 US buying guide breaks down premium public